During initiation of urate-lowering therapy such as allopurinol, how is colchicine used for prophylaxis?

Study for the WGU NURS6800 D116 Advanced Pharmacology Exam. Use flashcards and multiple-choice questions with hints and explanations. Prepare thoroughly for your exam!

Multiple Choice

During initiation of urate-lowering therapy such as allopurinol, how is colchicine used for prophylaxis?

Explanation:
Starting urate-lowering therapy like allopurinol can mobilize stored urate, which often triggers acute gout flares. To prevent this, low-dose colchicine is given as prophylaxis at the same time as starting allopurinol and is continued for a finite period—typically about 3 to 6 months or until uric acid targets are reached and flares are no longer occurring. After that, colchicine is stopped. This approach helps suppress early inflammatory attacks without requiring ongoing, indefinite use of colchicine. Colchicine is not contraindicated with allopurinol, and its role isn’t to boost allopurinol’s urate-lowering effect; it’s to prevent inflammatory flares during the initiation phase.

Starting urate-lowering therapy like allopurinol can mobilize stored urate, which often triggers acute gout flares. To prevent this, low-dose colchicine is given as prophylaxis at the same time as starting allopurinol and is continued for a finite period—typically about 3 to 6 months or until uric acid targets are reached and flares are no longer occurring. After that, colchicine is stopped. This approach helps suppress early inflammatory attacks without requiring ongoing, indefinite use of colchicine. Colchicine is not contraindicated with allopurinol, and its role isn’t to boost allopurinol’s urate-lowering effect; it’s to prevent inflammatory flares during the initiation phase.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy